Relapsed/Refractory Large B-cell Lymphoma

Also known as: Relapsed or Refractory Diffuse Large B-cell Lymphoma / Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL) / Relapsed or Refractory Diffuse Large B Cell Lymphoma / Relapsed/Refractory Diffuse Large B-cell Lymphoma / Relapsed/Refractory Diffuse Large B Cell Lymphoma / Relapsed /Refractory Diffuse Large B Cell Lymphoma / Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) / Relapsed/Refractory Large B Cell Lymphoma

DrugDrug NameDrug Description
DB16371GlofitamabA bispecific monoclonal antibody directed against CD20 and CD3 which is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma.
DrugDrug NamePhaseStatusCount
DB13915Axicabtagene ciloleucel1Terminated2
DB06769Bendamustine1Recruiting1
DB09052Blinatumomab1Completed1
DB00958Carboplatin1Recruiting1
DB00531Cyclophosphamide1Active Not Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB00531Cyclophosphamide1Terminated2
DB00773Etoposide1Recruiting1
DB01073Fludarabine1Active Not Recruiting1
DB01073Fludarabine1Recruiting1
DB01073Fludarabine1Terminated2
DB00441Gemcitabine1Recruiting1
DB01181Ifosfamide1Recruiting1
DB00480Lenalidomide1Recruiting1
DB15148Lenzilumab1Terminated1
DB16630OPB-1110771Recruiting1
DB00526Oxaliplatin1Recruiting1
DB09037Pembrolizumab1Completed1
DB09037Pembrolizumab1Withdrawn1
DB00073Rituximab1Recruiting2
DB00073Rituximab1Withdrawn1
DB15113Utomilumab1Terminated1
DB15035Zanubrutinib1Recruiting1
DB06769Bendamustine1 / 2Suspended1
DB18623C-CAR0391 / 2Recruiting1
DB00441Gemcitabine1 / 2Suspended1
DB09053Ibrutinib1 / 2Suspended1
DB00480Lenalidomide1 / 2Suspended1
DB00526Oxaliplatin1 / 2Suspended1
DB12240Polatuzumab vedotin1 / 2Suspended1
DB00073Rituximab1 / 2Suspended1
DB11942Selinexor1 / 2Suspended1
DB15044Tafasitamab1 / 2Suspended1
DB11581Venetoclax1 / 2Suspended1
DB00531Cyclophosphamide2Recruiting1
DB01073Fludarabine2Recruiting1
DB16371Glofitamab2Recruiting1
DB00480Lenalidomide2Recruiting1
DB14123Menthol2Active Not Recruiting1
DB16299Poseltinib2Recruiting1
DB11942Selinexor2Active Not Recruiting1
DB18457Zilovertamab vedotin2Active Not Recruiting1
DB00515Cisplatin2 / 3Recruiting1
DB01234Dexamethasone2 / 3Recruiting1
DB00441Gemcitabine2 / 3Recruiting1
DB00073Rituximab2 / 3Recruiting1
DB11942Selinexor2 / 3Recruiting1
DB13915Axicabtagene ciloleucel3Active Not Recruiting1
DB00531Cyclophosphamide3Active Not Recruiting1
DB01073Fludarabine3Active Not Recruiting1
DB12257Platinum3Active Not Recruiting1
DB13915Axicabtagene ciloleucelNot AvailableApproved for Marketing1